Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: RE: NAZ listing due to reverse split?

RE: NAZ listing due to reverse split?

posted on Apr 06, 2006 08:00PM
Pohl has already expressed his vision of where the company is headed (remember the umbrella with each spoke representing a profit-generating company?). It`s a fine vision, but much detailed planning will be required to ensure that wise investments are made.

I trust that Pohl and the board can handle the task. They got us this far ... gotta let them run with it.

As far as TPL and MMP goes, that`s the cash cow that will enable the company to grow, but our money intake depends exclusively on TPL`s tenacity in obtaining licensing agreements (unless IGNITE starts doing something). While it may be profitable for the short term (5-10 years), I don`t consider that dependence to be a good long-term business strategy.

Best Regards

Share
New Message
Please login to post a reply